Dear colleagues and friends of PATH,
Advances in science and technology are throwing open the doors for new opportunities in health and development in ways that were unimaginable just a few years ago—and upending our assumptions about what were once considered all-but-impossible challenges in global health.
New technologies and investments are expanding access to childhood vaccines, bednets, and other lifesaving interventions, driving steep declines in child mortality. Promising new vaccines and therapies for diarrheal disease, malaria, pneumonia, and other health threats have the potential to increase both life expectancy and quality of life. Mobile technology has reached the most remote corners of the globe, revolutionizing everything from health education to vaccine stock management.
PATH is harnessing the power of these innovations in pursuit of a bold ambition: to redefine the boundaries of what is possible in global health.
Our vision is unwavering—a world where innovation ensures that health is within reach for everyone. Our strategy is dynamic, channeling the tremendous potential of inventive ideas, new resources, groundbreaking collaborations, and cutting-edge discoveries into better health and opportunity for all.
This is innovation in motion.
Driving transformative innovation
From pioneering research to proven, on-the-ground delivery strategies, we accelerate smart ideas and bring lifesaving innovations to scale, connecting evidence-based solutions with the tens of millions of people who have the fewest resources and the greatest need.
We work in more than 70 countries and across nearly 200 projects to drive fresh thinking and new approaches to health technologies and systems, commercial markets, and community engagement. Our “innovation pipeline” of nearly 200 technologies and products accelerates the best ideas from prototype, testing, and validation to pilot introduction and national scale-up.
Below, you can learn about some of our most compelling accomplishments of 2012 that directly or indirectly touched the lives of more than 118 million people. These include work to advance new vaccine and drug candidates for diarrheal disease, pneumococcal disease, and malaria; prevent HIV infection, cervical cancer, and meningitis A; and expand access to new contraceptive options and safe water.
Accelerating our impact
PATH draws strength from our heritage of innovation and our proven track record of delivering high-impact tools, technologies, and strategies to transform global health. This includes our pivotal role in the development and delivery of new vaccines and immunization technologies now reaching tens of millions of people. Over the past decade, we have tripled our staff, nearly quadrupled our revenue, and added new capabilities across countries and our five platforms: community-based interventions, devices, diagnostics, drugs, and vaccines.
Now PATH is poised to deliver even greater impact. With new leadership, a sharpened strategy, and targeted investments in key impact areas, we are strengthening our ability to shape the next generation of life-changing advances that will reduce suffering and improve health around the world.
The power of partnership
Nothing PATH does would be possible without our partners and funders, and their essential contributions are highlighted throughout this report. PATH engages and connects hundreds of diverse partners in the private, public, and nonprofit sectors—from the community to the global levels—to bring innovative ideas to life. Our work is fueled by nearly 1,800 individual donors, foundations, corporations, and institutions—key collaborators in our work to turn bright ideas into breakthrough solutions. We are profoundly grateful for this support.
With our diverse network of partners, PATH is driving innovation that saves lives through far-reaching, long-lasting health solutions for families and communities. With your continuing support and collaboration, we will transform lives and open the doors of opportunity to new generations. Thank you for your commitment to global health.
President and CEO
Molly Joel Coye, MD, MPH
Chair, Board of Directors
President and CEO
Molly Joel Coye
Chair, Board of Directors